Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Apr;13(2):884-893.
doi: 10.1002/jcsm.12925. Epub 2022 Feb 11.

Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial

Affiliations
Randomized Controlled Trial

Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial

Álvaro Casas-Herrero et al. J Cachexia Sarcopenia Muscle. 2022 Apr.

Abstract

Background: Physical exercise is an effective strategy for preserving functional capacity and improving the symptoms of frailty in older adults. In addition to functional gains, exercise is considered to be a cornerstone for enhancing cognitive function in frail older adults with cognitive impairment and dementia. We assessed the effects of the Vivifrail exercise intervention for functional capacity, cognition, and well-being status in community-dwelling older adults.

Methods: In a multicentre randomized controlled trial conducted in three tertiary hospitals in Spain, a total of 188 older patients with mild cognitive impairment or mild dementia (aged >75 years) were randomly assigned to an exercise intervention (n = 88) or a usual-care, control (n = 100) group. The intervention was based on the Vivifrail tailored multicomponent exercise programme, which included resistance, balance, flexibility (3 days/week), and gait-retraining exercises (5 days/week) and was performed for three consecutive months (http://vivifrail.com). The usual-care group received habitual outpatient care. The main endpoint was change in functional capacity from baseline to 1 and 3 months, assessed with the Short Physical Performance Battery (SPPB). Secondary endpoints were changes in cognitive function and handgrip strength after 1 and 3 months, and well-being status, falls, hospital admission rate, visits to the emergency department, and mortality after 3 months.

Results: The Vivifrail exercise programme provided significant benefits in functional capacity over usual-care. The mean adherence to the exercise sessions was 79% in the first month and 68% in the following 2 months. The intervention group showed a mean increase (over the control group) of 0.86 points on the SPPB scale (95% confidence interval [CI] 0.32, 1.41 points; P < 0.01) after 1 month of intervention and 1.40 points (95% CI 0.82, 1.98 points; P < 0.001) after 3 months. Participants in the usual-care group showed no significant benefit in functional capacity (mean change of -0.17 points [95% CI -0.54, 0.19 points] after 1 month and -0.33 points [95% CI -0.70, 0.04 points] after 3 months), whereas the exercise intervention reversed this trend (0.69 points [95% CI 0.29, 1.09 points] after 1 month and 1.07 points [95% CI 0.63, 1.51 points] after 3 months). Exercise group also obtained significant benefits in cognitive function, muscle function, and depression after 3 months over control group (P < 0.05). No between-group differences were obtained in other secondary endpoints (P > 0.05).

Conclusions: The Vivifrail exercise training programme is an effective and safe therapy for improving functional capacity in community-dwelling frail/prefrail older patients with mild cognitive impairment or mild dementia and also seems to have beneficial effect on cognition, muscle function, and mood status.

Trial registration: ClinicalTrials.gov NCT03657940.

Keywords: Falls; Frailty; Functional capacity; Multicomponent exercise programme.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study flow diagram.
Figure 2
Figure 2
Within‐group SPPB score change distribution for both groups.
Figure 3
Figure 3
Changes in the functional categories at baseline, 1 month, and 3 months after intervention according to the Vivifrail classification: Disability (SPPB score 0–3 points), Frailty (4–6 points), Prefrailty (7–9 points), and Robust (10–12 points). P‐value after 1 month = 0.062. P‐value after 3 months ≤ 0.001.

Comment in

References

    1. Beard JR, Bloom DE. Towards a comprehensive public health response to population ageing. Lancet Lond Engl 2015;385:658–661. - PMC - PubMed
    1. Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet Lond Engl 2019;394:1365–1375. - PubMed
    1. Ward DD, Wallace LMK, Rockwood K. Frailty and risk of dementia in mild cognitive impairment subtypes. Ann Neurol. Published online March 11 2021;89:1221–1225. - PubMed
    1. Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment‐‐a review of the evidence and causal mechanisms. Ageing Res Rev 2013;12:840–851. - PubMed
    1. Rodriguez‐Mañas L, Fried LP. Frailty in the clinical scenario. Lancet Lond Engl 2015;385:e7–e9. - PubMed

Publication types

Associated data